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Abstract As clinical features in struma ovarii patients in the
absence of thyrotoxicosis are generally non-specific and re-
semble ovarian malignancy, preoperative radiological diagno-
sis becomes all the more relevant in order to avoid ovarian
cancer type surgery (including bilateral salpingo-
oophorectomy, hysterectomy, omentectomy and occasionally
appendectomy) for this usually benign and rare ovarian mass.
As struma ovarii is an uncommon entity, it is all the more
important to perform state-of-the-art magnetic resonance
(MR) imaging, including high-resolution imaging and
diffusion-weighted imaging. The goal of this review paper is
to give an update of the key findings of both benign and
malignant struma ovarii and to present an unusual case of a
purely cystic ovarian struma.
Key Points
• Clinical features in struma ovarii are generally non -specific
and resemble ovarian malignancy.
• Pre -operative radiological diagnosis is important to
avoid ovarian cancer type surgery (bilateral salpingo-
oophorectomy, hysterectomy, omentectomy and occasional-
ly appendectomy).
• State -of-the -art MR imaging might help to characterise this
unusual ovarian mass .
• Struma ovarii can occasionally present as a purely cystic
lesion .
• However, the role of imaging to identify struma ovarii
preoperatively remains limited .
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Introduction
Struma ovarii is a very rare and usually benign ovarian tumour
that was first described in 1889 by Boettlin [1], who observed
the presence of thyroid follicular tissue in ovaries. It accounts
for 0.3–1 % of all ovarian tumours [2] and for 3 % of all
mature teratomas [3]. Struma ovarii is the most common form
of monodermal teratoma and is characterised by the presence
of macroscopically and histologically detectable thyroid tissue
containing variable-sized follicles with colloid material [2].
Thyroid tissue is observed not uncommonly in 5–15 % of all
dermoid tumours, but in order to qualify as a struma ovarii, the
proportion of thyroid tissue present must comprise more than
50 % of the overall tissue [4].
Struma ovarii presents as a multi-cystic mass with a peak
incidence in the 5th decade of life and peak age at presentation
of 50 years [5]. When uncomplicated, the clinical manifesta-
tions of struma ovarii provide only limited information and
often overlap with those of other diseases. As most patients
are asymptomatic or present without specific features, diag-
nosis is often delayed until the development of symptoms
related to ovarian torsion, hyperthyroidism or ascites. A study
performed by Yoo et al. in 2008 [6] states that the most
common initial symptoms at presentation are abdominal pain
and distension or a palpable mass. Vaginal bleeding has also
been described. Cases presenting with facial flushing and
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palpitations are rare [3]. Such clinical signs of thyrotoxicosis
are reported in only about 5 % of struma ovarii patients [7, 8].
Meigs’ syndrome is characterised by the presence of ascites
and pleural effusion in association with a benign ovarian
tumour, typically an ovarian fibroma. Pseudo Meigs’ syn-
drome, on the other hand, is defined by the presence of ascites
and a pleural effusion in association with either a mature
teratoma, leiomyoma, cystadenoma or an ovarian malignancy
[9]. In both syndromes, the ascites and pleural effusion resolve
after the ovarian lesion is excised. Pseudo Meigs’ syndrome is
occasionally encountered in benign struma ovarii [10, 11].
According to several authors [12–15], a variable occurrence
of ascites in patients with struma ovarii, ranging from 17 % to
33.3 %, has been observed and it is thought that struma ovarii
should be included in the differential diagnosis of a pelvic
mass that presents with ascites, hydrothorax and elevated
CA125 tumour marker [16].
However, CA125, the widely accepted tumour marker of
ovarian carcinoma, is of little clinical value in struma ovarii
patients as it can be elevated in both benign and malignant
subtypes and because it is not consistently elevated even in
malignant cases [6]. It has been postulated that an increased
level of CA125 in struma patients is not a direct consequence
of the presence of a tumour as such, but rather a secondary
effect due to the presence of ascites [17].
Imaging findings in struma ovarii
Struma ovarii is a rare type of mature teratoma, but its
imaging features are rather distinct. Whilst immature ter-
atomas are known to be predominantly solid with small
foci of fat, mature cystic teratomas or dermoid cysts are
known to be predominantly cystic, present as a fat-
containing mass and are often associated with calcifica-
tions as well as an enhancing nodule-forming soft-tissue
component [3]. Diagnosis of uncomplicated teratomas
using computed tomography (CT) and magnetic reso-
nance (MR) imaging is fairly straightforward because
both techniques are highly sensitive in the detection of
fat within the tumour, presenting as negative attenuation
on CT [7]. On MRI, three methods have been used to
distinguish the fatty contents of the mature cystic teratoma
from those of endometriomas or other haemorrhagic cysts.
First, chemical shift artefact in the frequency encoding
direction can be used to detect fat and to distinguish fat
from haemorrhage [18]. Second, gradient-echo imaging,
using an echo time in which fat and water are in opposed
phases, can demonstrate fat–water interfaces and mixtures
of fat and water [19]. Third, sequences with frequency-
selective fat saturation will suppress the high signal of the
intralesional fat in teratomas and help distinguish them
from haemorrhagic lesions [3]. MR imaging with this
latter technique allows accurate differentiation between
teratomas and haemorrhagic cysts and is preferable to
the other techniques [3]. The key features of a mature
teratoma using water-only and fat-only T1 technique and
diffusion-weighted imaging are demonstrated in Fig. 1. Of
note is the restricted diffusion present in the sebaceous
material within the cyst (Fig. 1).
Unlike the most common types of teratoma, namelymature
and immature subtypes, struma ovarii does not demonstrate
lipid material on either CT or MRI [3]. When struma ovarii is
accompanied by foci of fatty tissue, they can be considered as
areas of dermoid cyst associated with struma ovarii [20]. In
these circumstances, the presence of dermoid cyst can be a
strong clue to suspect struma ovarii [21].
Scintigraphy
Scintigraphy performed with either iodine-123 or iodine-131
[22] is useful for diagnosing a hyperfunctioning struma ovarii
on the basis of higher uptake of the radionuclide by the
ovarian mass compared with the thyroid gland (Fig. 2).
Ultrasound
Whilst a mature teratoma or dermoid cyst presents on
ultrasound as a cystic lesion with a densely echogenic
tubercle (termed a Rokitansky nodule or nidus), which
projects into the cystic lumen [3], as well as associated
sound attenuation due to sebaceous material and hair
within the cyst cavity or recognisable fluid–fluid levels
from the sebum floating above aqueous material [3, 23],
the ultrasound features of a struma ovarii are quite indis-
tinct (Fig. 3). As struma ovarii presents with a variety of
non-specific appearances and usually manifests as a
multilocular cystic ovarian mass with solid components
of various amounts, the ultrasound typically demonstrates
these non-specific heterogeneous solid cystic features [3].
CT
Although findings are generally non-specific, CT demon-
strates the complex appearance with multiple cystic and
solid areas, reflecting the gross pathological appearance of
the struma. Shen et al. [24] found high-density cysts with
CT values ranging from 58 to 98 Hounsfield units (HU) in
68 % of their cohort of 12 cases. They hypothesised that
the appearance of such high-density cysts in a pelvic
mass, especially when greater than 90 HU [24], are
caused by both thyroglobulin and thyroid hormones in
the ovarian follicular thyroid tissue attenuating the X-ray
beam. Shen et al. [24] proposed that these high-density
cysts might be a characteristic feature of struma ovarii on
CT (Fig. 4). Ikeuchi et al. [21] in a retrospective study of
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26 cases concluded that on CT, high attenuation areas and
calcifications in the solid components of the struma are
common findings.
MRI
The struma has features overlapping with those of malignant
ovarian epithelial tumours, as it presents either as a unilateral
complex adnexal mass often associated with ascites, or as a
multi-cystic mass with solid components and multiple cystic
locules. Thick septations, measuring 3–10 mm [13], within
the lesion have been described [25] and the peripheral cyst
wall measures 7–15 mm in thickness [13].
On MR imaging, the signal intensity of the various
solid components varies [7]. The classic MR imaging
appearance of struma ovarii includes multiple intra-
cystic solid areas, representing thyroid tissue, that are of
low signal intensity on T2-weighted images and interme-
diate signal intensity on T1-weighted images [25]. The
cystic spaces, on the other hand, demonstrated both high
and low signal intensity on T1- and T2-weighted images
[26, 27]. The high-density spaces seen on CT (especially
if >90 HU) were of high signal intensity on T1-weighted
imaging and low signal intensity on T2-weighted imaging
[24]. Some cystic spaces demonstrated low signal inten-
sity on both T1- and T2-weighted images. This pattern of
signal intensity on T1- and T2-weighted imaging was
found to be due to the thick, highly viscous, gelatinous
colloid material in large follicles of the struma [25–28].
Joja et al. [28] stated that the variety of signal intensities
seen on MR images in the cystic components depends on
the degree of condensation of thyroglobulin and thyroid
hormones, and it now recognised that this variable signal
intensity is highly characteristic of struma ovarii [25]. In a
cohort of 26 cases, Ikeuchi et al. in 2012 [21] concluded
that a struma typically presents as a lobulated multicystic
lesion with solid components, which frequently includes
loculi of low signal intensity on T2-weighted imaging and
punctuate foci of high intensity on T1-weighted images.
Imaging features of struma ovarii at 3 T are illustrated in
Figs. 5 and 6.
Imaging following an intravenous contrast agent is known
to demonstrate marked enhancement of the thick septations
and locally thickened wall seen in struma ovarii [25]. The
Fig. 1 Three-tesla MR images
of a mature teratoma or dermoid
cyst arising from the left ovary
in a 53-year-old patient. The
fatty component in the lesion is
hyperintense on the 3D-LAVA
fat-only T1-weighted image (a)
and hypointense on the water-only
T1-weighted image (b) (arrows).
c T2-weighted high-resolution
image shows the fatty component
within the lesion to be hyperintense
(arrow). The nidus itself contains
a fatty component that is also
hyperintense on 3D-LAVA fat-only
T1-weighted image (a) and
hypointense on the water-only T1-
weighted image (b) (arrowheads).
d Diffusion-weighted image using
a b value of 1,200 s/mm2 shows
a high signal intensity rim
representing restricted diffusion
from sebaceous material
surrounding the nidus and
punctuate areas of restricted
diffusion scattered throughout
the nidus (arrowhead). The
pedunculated uterine fibroid (T)
at the level of the right lateral aspect
of the uterus presents with typical
hypointensity on T2 (c) without
associated restricted diffusion (d)
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solid components, corresponding microscopically to thyroid
tissue, also demonstrate strong enhancement [25] and, togeth-
er with the multilobulated surface of the struma, gives rise to a
“lacy” pattern (Fig. 5).
Intuitively, we assume that the higher spatial resolution
achievable at 3 T allows this lacy pattern to be more conspic-
uous. It goes without saying that the use of a spasmolytic
(when no contraindication) and significant patient cooperation
are both mandatory in order to achieve the spatial resolution
required to enable detection of such textural detail from
imaging.
This lacy pattern is also apparent on the diffusion-
weighted images: the hyperintense solid components dem-
onstrating restricted diffusion are interspersed with cystic
areas (either hyper- or hypointense on T2-weighted imag-
ing) showing increased diffusion (Figs. 5 and 6). From
our own experience in a small cohort (unpublished data),
apparent diffusion coefficient (ADC) values in the cystic
areas of a benign struma are high, while the solid areas
present with ADC values within the benign range. The
lowest ADC values in our small benign struma cohort of
three cases reached up to 1.2 × 10-3 mm/s2.
Although MR features of struma ovarii overlap with those
of other epithelial ovarian lesions, when MR imaging shows a
Fig. 2 a Whole-body I-123 imaging shows significantly increased I-123
uptake within the left hemi-pelvis in a 61-year-old woman with a history
of thyrotoxicosis treated with radioiodine treatment twice over the last
30 years, who ultimately had a thyroidectomy which showed Graves
disease but who remained thyrotoxic post surgery. b The area of in-
creased uptake within the left hemi pelvis corresponds on the low-dose
CT to an 8-cm left-sided pelvic mass (M) in keeping with a confirmed
struma ovarii
Fig. 3 Difference in ultrasound features between struma ovarii and
ovarian dermoid cyst. a Predominantly cystic struma ovarii typically
mimicking an epithelial ovarian tumour (either cystadenoma or border-
line ovarian tumour) in the right ovary of a 51-year-old patient presenting
with non-specific abdominal cramps. Some thicker septations are seen
(arrow) between otherwise cystic areas presenting with anechoic fluid
and posterior acoustic enhancement (A).Right 1.5-cm (b) and left (c) 5.1-
cm dermoid cyst in a 24-year-old woman. Both lesions on ultrasound
have the typical pattern of high attenuation within the cyst (arrows)
representing its fatty component
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unilateral complex mass with a multilobulate surface and
thickened septa, is composed of multiple cysts of variable
signal intensity (in keeping with thick viscous colloid fluid)
and demonstrates intensely or moderately enhancing solid
components with a “lace appearance”, struma ovarii should
be included in the differential diagnosis with high probability.
Unusual imaging findings of struma ovarii
Cystic struma ovarii
A non-cystic struma usually appears as a soft tissue mass, either
as a solitary finding or more commonly against a background
of a dermoid cyst. Very rarely struma ovarii falls into the
category of cystic struma based on its macroscopic appearance.
Yen et al. [29] reported one case of a struma ovarii with features
on MR imaging that were indistinguishable from a benign
multi-cystic ovarian tumour. Only a few cases of cystic struma
ovarii have been reported in the literature [29–32]. On MRI, a
cystic struma ovarii resembles a cystic epithelial ovarian lesion
(Fig. 7). The diagnosis of a cystic struma ovarii is usually made
on histopathology. It is recommended that cystic struma ovarii
should be considered when evaluating cystic ovarian tumours
whose features are not obviously those of another tumour type.
If this is the case, a careful search for thyroid follicles should be
undertaken. Immunohistochemical staining for thyroglobulin
in difficult cases is recommended [32].
Malignant struma ovarii
Malignant transformation of a mature cystic teratoma is a
complication, reported to occur in only 1–2 % of the cases
Fig. 4 Venous phase enhanced CT image in a 69-year-old woman shows
a well-delineated lesion within the left hemi-pelvis. The peripheral solid
component of the lesion shows marked contrast uptake while two well-
delineated cystic areas of low signal intensity (C) are seen centrally
within the cyst. At histopathology this proved to be a struma ovarii with
a papillary microcarcinoma component
Fig. 5 Three-tesla MR images in
a 61-year-old patient (same as in
Fig. 2) with confirmed benign
struma ovarii of the left ovary. An
8-cm left oval-shaped complex
multiloculate lesion is seen on the
T2-weighted (a), diffusion-
weighted images with b =
1,200 mm/s2 (b) and T1 fat-
saturated images (LAVA) pre-
gadolinium (c) and post-
gadolinium (d) within the left
hemi-pelvis. The solid portion of
the mixed solid and cystic lesion
presents with the typical low signal
intensity on the T2-weighted
image (a) and intermediate signal
intensity on the T1-weighted
image (c) (arrows). d These solid
components enhance markedly
(arrow) which together with the
multilobulate surface resemble a
“lacy” pattern. b This lacy pattern
in keeping with solid thyroid tissue
is also obvious on the diffusion-
weighted images (arrow)
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[33], usually in the 6th or 7th decade of life. In total, up to 5–
10 % of all cases of struma ovarii are reported to be malignant
[34–36]. Such rare cases of carcinoma, usually papillary thy-
roid cancer, within a struma ovarii have been reported [5].
The diagnosis of malignant struma ovarii is usually based
on histological features of the resected ovary, as no specific
imaging features are available to detect malignant struma.
However, as malignant struma ovarii are teratomas, the fol-
lowing criteria apply to detect malignancy: CT and MR im-
aging findings of malignant transformation of ovarian terato-
ma include invasive growth of large, irregularly marginated
Fig. 6 Three-tesla MR images of
a predominantly cystic struma
ovarii (same patient as Fig. 2a).
T2-weighted high-resolution
image (a), unenhanced (b) and
enhanced (c) T1 fat-saturated
LAVA image and diffusion-
weighted image b = 1,200 mm/s2
(d) at the same slice level show
the multiloculate lesion centrally
within the pelvis anterior to the
uterus. a The cystic components
of the struma present with high
and low signal intensities on T2-
weighted imaging. b The cystic
areas with high signal intensity on
T1 mimic a mucinous epithelial
tumour. c Contrast-enhanced T1-
weighted image illustrates a small
solid component presenting with
a lacy pattern of enhancement
(arrow). A linear cystic area in
keeping with thick gelatinous
fluid demonstrates very low
signal on T2-weighted (e) and on
unenhanced T1-weighted
imaging (f) (arrow)
Fig. 7 Benign cystic struma ovarii in an 81-year-old woman, presenting
with abdominal swelling and discomfort and normal CA125. a
Ultrasound shows thick septations (arrow ) within a cystic lesion.
Three-tesla T2-weighted high-resolution images (b), unenhanced (c)
and enhanced (d) T1 fat-saturated LAVA, diffusion-weighted images
b =1,200 mm/s2 (e) and corresponding ADC map (high ADC values
shown in red ) (f ) through the same slice are shown. The case
macroscopically mimicked a cystadenoma. g On histological
examination, however, although the cyst loculi were lined by flattened
low columnar indifferent epithelium, there were several small areas where
micro- and macro-follicles of thyroid tissue were evident. The diagnosis
was confirmed with the aid of positive immunostaining for both
thyroglobulin (h ) and TTF1 antibodies. No other teratomatous
component was identified despite review of the tissue blocks
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soft-tissue components through the tumour wall or irregular
soft-tissue components within the tumour [37] (Figs. 8 and 9).
In view of the ascites frequently present in benign struma,
distinguishing benign frommalignant struma is difficult in the
absence of extracapsular extension (Fig. 8). The potential
future role of diffusion-weighted imaging to distinguish be-
nign from malignant struma remains to be investigated in a
large multicentre trial. In our limited experience ADC values
in malignant struma overlapped with those of benign struma.
However, in this limited cohort of only two cases, the tumour
burden in the struma on histopathology was limited.
In many cases of malignant struma, in which the presence
of malignancy within the struma was diagnosed on the basis
of histological criteria alone, the clinical behaviour was be-
nign [15]. However, distant metastasis has been reported to be
a very uncommon feature of struma ovarii. Sites of common
metastasis from malignant struma are: the omentum, mesen-
tery, lymph nodes via the peritoneum, liver, brain, bone, lungs
and contralateral ovary via a haematogenous route [38, 39].
Metastasis is reported to be possible after removal of the
malignant ovarian struma [40]. Such a metastasis to the lum-
bar spine has been described in a 32-year-old woman [40]. An
extreme case was where a distant metastasis was discovered
26 years after initial diagnosis had been reported [12].
In addition, the role of iodine imaging has been
emphasised in the detection of recurrent disease after
termination of therapy [41].
Collision tumour
Strumal carcinoid
A strumal carcinoid is a unique tumour that is characterised by
the presence of both carcinoid and thyroid tissue within a
struma ovarii. Clinical manifestations of hyperandrogenism
or hyperoestrogenism (8 %) and hyperthyroidism (8 %) have
been seen in association with strumal carcinoids. Occurrence
of associated carcinoid syndrome is rare [35, 42].
Coexistence of Brenner tumour and struma ovarii
Ovarian tumours composed only of Brenner tumour and stru-
ma ovarii where both elements are present within the tumour
are very rare. Both components of such tumours present with
different immunohistochemistry markers [43].
Differential diagnosis
Imaging does not allow the differentiation of non-functioning
struma ovarii from other cystic masses [5]. When struma
ovarii is not associated with hyperthyroidism, the differential
diagnosis includes: mature cystic teratoma without fatty tis-
sue, cystadenoma or cystadenocarcinoma, endometriosis,
tubo-ovarian abscess and metastatic tumour, because the im-
ages of such lesions may resemble those of struma ovarii [5].
Mucinous cyst should be considered when the lesion pre-
sents with high signal intensity locules on T1-weighted imag-
ing, typical of mucinous content, and associated septations,
but such features are also typical of struma. Struma ovarii is
generally a much more complex lesion compared with mu-
cinous cystadenoma. In a cystadenoma, lacy pattern contrast
enhancement is not present. Both mucinous cystadenoma as
well as struma present with locules containing hyperintense
content on T1, representing the mucinous material in the first
and thyroglobulin in the latter [28]. The very low signal on T1
and T2 of the gelatinous colloid in the struma may be over-
lapping with features representing focal haemorrhage within a
mucinous tumour, but might be more in favour of struma.
Endometriotic cysts present with very low SI on T2-
weighted imaging, while the signal intensity on T1-weighted
imaging is usually very high. Hence, discrimination from
struma ovarii is generally not difficult.
Fig. 8 Three-tesla T2 high-
resolution images of a benign
and malignant struma ovarii for
comparison. a Sagittal image
showing the largemixed solid and
cystic malignant struma (arrow).
b Axial plane image through a
benign struma shows an equally
complex large lesion (arrow). a ,
b Ascites is present in both the
benign and the malignant case (A)
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A tubo-ovarian abscess presents with typical clinical signs
of pain, fever and hyperleucocystosis, discrepant to the
struma’s often more insidious presentation.
The most challenging differential diagnosis is with ovarian
cancer. Malignant epithelial cysts serous as well as mucinous
type can present with very complex features, resembling the
architecture of the struma’s lacy pattern. Moreover, when
haemorrhage is present in ovarian cystadenocarcinoma, this
may present with similar features to the colloid in struma. In
the absence of omental disease, the differential with malignant
epithelial cyst remains challenging.
Treatment and impact of preoperative diagnosis in struma
ovarii
Treatment for benign struma is surgical resection. Hence, for
women wishing to retain fertility, unilateral salpingo-
oophorectomy may still be a feasible option in the absence
Fig. 9 Malignant struma arising
from the left ovary in a 40-year-
old woman presenting with
abdominal distension and lower
abdominal pain. CA-125 levels
were elevated at 1,075 kU/l
(normal value <12 kU/l). a
Ultrasound shows a mixed solid
cystic mass with predominantly
solid features. On the 3-T T2-
weighted high-resolution (b),
unenhanced (c) and enhanced (d ,
f) T1 fat-saturated LAVA and
diffusion-weighted images b =
1,200mm/s2 (e), imaging features
resemble a mucinous
cystadenocarcinoma. d , e The
lacy pattern caused by the
enhancing solid elements
(representing thyroid tissue) can
be seen on T1 post-contrast
imaging (d) and diffusion
imaging (e) might be the only
feature to suggest a struma. d , f
Ascites is present (A) as well as
extracapsular extension which is
seen as tumour nodules on the
capsular surface (arrow). d , e
Some contrast medium uptake is
shown in the tissues between the
ovary and pelvic sidewall on the
right (arrow). b , d , e A simple
cyst arising from the right ovary
does not present with restricted
diffusion (arrowheads)
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of extracapsular extension and distant metastases [44]. As the
few reported imaging features of ovarian struma overlap with
those of other lesions, such as ovarian carcinoma, it becomes
all the more relevant to be aware of contemporary imaging
findings, including state-of-the-art MRI and diffusion-
weighted imaging, in order to attempt preoperative diagnosis
in these challenging and complex lesions. Failure to charac-
terise this rare and usually benign mass as benign may lead to
surgical overtreatment when ovarian cancer type surgery (in-
cluding bilateral salpingo-oophorectomy, hysterectomy,
omentectomy and occasionally appendectomy) is performed.
An adjuvant treatment technique that has been suggested
for residual, metastatic or recurrent disease of malignant stru-
ma is radioiodine therapy, which has been reported to result in
favourable outcomes [4]. In patients presenting with multiple
metastatic lesions, or for those who absorb radioiodine poorly,
external beam radiation has been proposed [39].
Summary
At present, the role of imaging in the preoperative character-
isation of struma ovarii is limited. The small number of cases
of struma ovarii reported in the literature is a significant
limitation. Further study in a larger cohort of these rare ovarian
tumours through a multicentre collaboration would be useful
to see whether there is a novel way of imaging to facilitate
preoperative diagnosis and to improve distinction between
benign from malignant struma ovarii. Such future research
needs to establish the potential role of novel imaging tech-
niques, such as diffusion-weighted imaging, in this rare tu-
mour. Intuitively, high field, high spatial resolution, 3-T im-
aging allows higher conspicuity of the typical lacy pattern of
the struma post-contrast, but this remains to be investigated.
Because 95 % of struma ovarii are benign and can occur in
premenopausal women, and because the surgery performed is
quite different for benign and malignant ovarian tumours,
such preoperative radiological diagnosis, however challeng-
ing, is very important.
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